Polymyalgia Rheumatica Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are suspected to have a condition called GCA (Giant Cell Arteritis), meaning your doctor thinks you may have it but it has not been confirmed yet
- You are over 50 years old
Who may not be able to join:
- You have previously been diagnosed with GCA (Giant Cell Arteritis)
- You have a history of a condition called polymyalgia rheumatica (a disorder causing muscle pain and stiffness) and did not have a specific type of full-body scan called a PET scan at the time of your diagnosis
- You have a history of retinal disease (a condition affecting the back of the eye), a condition affecting the nerves in the brain or spinal cord, or a condition where pressure inside your skull is too high
- You have taken high-dose steroid medication (corticosteroids above 0.5mg/kg) at any point in the last 2 weeks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Omar AL TABAA, Dr, Hôpital NOVO
Phone: +330130754131
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess whether the Optic Nerve Sheath Diameter (ONSD) measured by orbital ultrasound serves as an effective diagnostic marker for Giant Cell Arteritis (GCA)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.